| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | Chief Financial Officer | Stock option (right to buy) | 2,400,000 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | 03 Feb 2026 | 1 | $0 | 4 | Chief Financial Officer | 05 Feb 2026, 16:35 |
| SABS | SAB Biotherapeutics, Inc. | 26 Aug 2025 | 1 | $0 | 4 | Chief Financial Officer | 28 Aug 2025, 17:10 |
| SABS | SAB Biotherapeutics, Inc. | 12 Aug 2024 | 1 | $0 | 4 | Chief Financial Officer | 13 Aug 2024, 17:00 |
| SABS | SAB Biotherapeutics, Inc. | 26 Jul 2024 | 0 | $0 | 3 | Chief Financial Officer | 31 Jul 2024, 17:00 |